###begin article-title 0
###xml 70 75 <span type="species:ncbi:9606">human</span>
Vascular endothelial growth factor receptor-1 (VEGFR-1) expression in human corneal fibroblast decreased with age
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 230 235 <span type="species:ncbi:9606">human</span>
Mechanisms by which fibroblast networks between stromal lamellae are laid in the corneal stroma are far from clear. We have investigated the role of vascular endothelial growth factor receptors (VEGFRs) by in vitro studies in the human corneal network formation obtained from donors whose ages ranged from 19 to 89 years.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
Corneal fibroblasts were prepared from cornea donations. The functional properties of these cells to form networks were analyzed using a semi solid matrix (substratum) of Matrigeltrade mark. The presence of VEGF receptor-1 (VEGFR-1) and the functionality in these fibroblasts were investigated using immunofluorescence, molecular analysis (gene microarray, reverse transcription polymerase chain reaction [RT-PCR] and VEGFR siRNA transfections), and cell culture.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 463 470 454 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-1</italic>
Corneal fibroblasts from 61 donors were classified into two groups according to whether they formed (82%) a reticulum on Matrigeltrade mark or not (18%). By RT-PCR and immunofluorescence analysis, we showed that corneal fibroblasts expressed VEGFR-1 (mRNA and protein). Further, cell culture analysis revealed that only the network (reticulum) forming corneal fibroblast expressed VEGFR-1 in contrast to non network-forming fibroblasts. Use of inhibitors such as VEGFR-1 siRNA transfection or neutralizing antibody (Avastintrade mark) indicated that VEGFR-1 was essential to the formation of the corneal network in vitro.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-1</italic>
###xml 171 178 171 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-1</italic>
The cell reticulum formation seemed to be directly related to the expression of VEGFR-1 in the corneal fibroblast, and this expression decreased with age. The decrease in VEGFR-1 expression is probably related to the diminution of autocrine functions, which may alter the overall tissular homeostasis. This may culminate in the gradual development of poor vision, which is observed in certain pathologies and in aging individuals.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
The cornea is a highly differentiated tissue, rich in extracellular matrix (ECM) synthesized by its cell constituents. The corneal matrix is characterized by a well-defined supramolecular structure that ensures the dual function of the cornea, transparency as well as inner-eye tissue protection. ECM disorders have been associated with various eye diseases such as corneal macular dystrophy and Marfan's syndrome.
###end p 10
###begin p 11
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 529 530 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 595 596 595 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 625 626 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 627 628 627 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 1206 1208 1206 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 1439 1441 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 1913 1914 1913 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 517 520 <span type="species:ncbi:10116">rat</span>
###xml 544 550 <span type="species:ncbi:9986">rabbit</span>
###xml 555 560 <span type="species:ncbi:9606">human</span>
The human corneal stroma is a stacking of collagenous lamellae. They are colonized with keratocytes (quiescent cells) or following wound healing, with corneal fibroblasts or myofibroblasts (activated cells derived from keratocytes) [1-3]. Several investigations have shown that the arrangement of keratocytes within the corneal stroma is an essential mechanism in the maintenance of corneal transparency. Scanning electron microscopy has revealed a network of flat cells with many small dendritic bifurcations in the rat cornea [4]. Studies on rabbit and human cornea using immunocytochemistry [5,6] and electron microscopy [7-9] have described the existence of gap junctions between keratocytes. Flat sections of the cornea show that the fibroblasts have long branching processes or digitations, which extend in several directions from the cell body and establish contacts with similar processes of other cells in the vicinity. According to several recent reports [10], these cells appear to form a syncytium-like structure. This however contradicts earlier observations by others who used electron micrographs, which showed the presence of almost a 200 A wide intercellular space separating these cells [11]. The structural morphology of intercellular connections of the corneal fibroblast was shown in flat sections of the corneal stroma. It reveals the existence of a functional circuit of a communication network between keratocytes [10]. However, knowledge of the detailed mechanisms involved in the corneal fibroblast network formation still eludes us. We have been interested in the process of corneal fibroblast reticulation for a few years now and have tried to further our understanding through biochemical and cell biology studies. The fibulins, a family of the ECM proteins, were characterized by our group recently for their implication in the reticulation of organ shape and stromal cell motility [1].
###end p 11
###begin p 12
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
Due to its avascularity, the cornea has not only served as the principal in vivo model system for studying angiogenesis but also as a convenient model for vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) signaling pathways in several physiopathological disorders [12].
###end p 12
###begin p 13
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
VEGF encompasses a family of structurally related proteins that include PlGF (placental-derived growth factor), VEGF-A, VEGF-B, VEGF-C, VEGF-D, and VEGF-E. The VEGF receptor family in mammals contains three members, VEGFR-1 (fms-like tyrosine kinase-1 or flt-1), VEGFR-2 (kinase insert domain containing receptor/fetal liver kinase-1 or KDR/flk1), and VEGFR-3 (fms-like tyrosine kinase-4 or flt-4) in addition to a co-receptor, NRP1 (neuropilin). These factors directly participate in the genesis of blood capillaries and lymphatic vessels [13-18].
###end p 13
###begin p 14
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
It has been shown that corneal wound healing requires the action of several angiogenic factors that include VEGF and b-FGF (basic fibroblast growth factor) [19-21]. The circulating soluble receptors, VEGFR-1 and VEGFR-3, play a crucial role in the avascularity of the cornea. It acts by binding free VEGF thereby making it unavailable for binding to receptors on cell membranes [22,23].
###end p 14
###begin p 15
###xml 405 410 <span type="species:ncbi:9606">human</span>
Knowledge regarding the role of VEGF, the mechanisms underlying corneal stromal cell integrity, and the complex inter-cellular network formation is still very scant. Our laboratory has been interested in understanding the complexity involved in corneal integrity and has undertaken several lines of research aimed at it for the past few years. In the present study, we focus on the role of VEGFR-1 in the human corneal stromal fibroblast network organization in vitro.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Isolation and primary culture of corneal stromal cells
###end title 17
###begin p 18
###xml 187 188 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 558 559 548 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1065 1066 1055 1056 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1075 1076 1065 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1121 1122 1111 1112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 407 411 <span type="species:ncbi:9913">calf</span>
Human corneas were obtained from the "Banque Francaise des yeux" after informed consent of the donors in agreement with the revised rules of the Helsinki Protocol. Pieces of cornea 2-3 mm2 in size were gently scratched to remove epithelial cells. The corneal pieces were seeded on 24 well plates containing Dulbecco's Modified Eagle's Medium:F12 (DMEM/F12; PAA, Mureaux, France) supplemented with 10% fetal calf serum (FCS), penicillin (100 U/ml), and streptomycin (100 microg/ml; PAA) and incubated at 37 degreesC in a humidified atmosphere containing 5% CO2. Non-adherent cells were removed and discarded after three days and the culture dishes were washed with 1x phosphate buffer saline (1x PBS; PAA). After an additional week in culture, some cells began to spread out of the corneal explants. These cells were primary corneal stromal cells and were detached with trypsin treatment (PAA) for 15 min. The cells were centrifuged, and the pellet was washed, resuspended, and seeded in the same complete medium for incubation for two weeks in six-well plates (4x104 cells/cm2) in a humidified atmosphere containing 5% CO2 at 37 degreesC. Samples were taken and used for experiments from the first passage onwards through the sixth.
###end p 18
###begin title 19
Wound healing test
###end title 19
###begin p 20
###xml 380 383 380 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7 </sup>
Motility and adhesion were analyzed on cells grown to 80% confluency in 24 well culture dishes coated with "Attachment Factor" (PAA). Then, four scars/wounds (two vertical and two horizontal) were made using a blunt glass tip. The dishes were then incubated in a DMEM/F12 medium containing only 2% FCS, and triplicate dishes were assigned for (a) the control, (b) with Avastin (10-7 M), (c) with VEGF-A (100 ng/ml), and (d) with VEGF-C (100 ng/ml). In the presence of 2% FCS, cell proliferation did not occur, but cell viability was unaffected. The number of cells that migrated into the wound track were counted during incubation at intervals of 9 h, 18 h, 24 h, 48 h, and 72 h and the mean number of cells computed (n=4).
###end p 20
###begin title 21
Immunocytochemistry
###end title 21
###begin p 22
###xml 304 310 <span type="species:ncbi:9913">bovine</span>
###xml 511 515 <span type="species:ncbi:9925">goat</span>
One million cells were cultured for 24 h in glass chamber slides (Labtek(R); Nunc, Naperville, IL) in complete DMEM/F12. Cells were washed with a serum-free medium and fixed for 15 min with 3% paraformaldehyde in 1x PBS. After three washes with PBS, cells were further incubated for 20 min with 1% (w/v) bovine serum albumin (BSA; Sigma-Aldrich, St Louis, MO) to avoid non-specific binding. Cells were exposed to VEGFR-1 antibody for 1 h at 4 degreesC. After three washes with PBS, cells were treated with anti-goat secondary biotinylated antibody for 1 h at 4 degreesC (1:100 dilution). Cells were washed twice in PBS-BSA and exposed to Streptavidin-Fluorescein (Sigma-Aldrich) for 45 min at 4 degreesC. The antibody fluorescence was observed on slides using a Nikon fluorescence microscope (Nikon, Paris, France).
###end p 22
###begin title 23
Matrigeltrade mark assays
###end title 23
###begin p 24
###xml 482 483 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 88 94 <span type="species:ncbi:10090">murine</span>
The cell motility and cell-cell contacts were assessed on Matrigeltrade mark, a natural murine fibrosarcoma extracellular matrix (BD Biosciences, San-Jose, CA). Matrigeltrade mark provides a physiologically relevant environment for studies of cell morphology, migration, and invasion as cultures grown on top of it presents a two-dimensional situation for cellular network formation. A 96 well microplate was coated with 35 microl of Matrigeltrade mark. After 1 h at 37 degreesC, 104 cells in 200 microl of DMEM:F12 and VEGF (100 ng/ml; PromoCell GmbH, Heidelberg, Germany) were seeded into each well. Culture cells were observed using an inverted microscope, and cell-cell contacts (intercellular junctions) as well as tubular reticulum formation were counted at 3 h intervals and the results plotted as a histogram.
###end p 24
###begin title 25
Analysis by gene array
###end title 25
###begin p 26
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 309 310 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 686 688 684 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 108 112 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The gene expression patterns of corneal primary culture cells and human corneal fibroblasts immortalized by SV40 T antigen transfection [24] were analyzed and compared by a two-color topic-defined microarray (PIQOR Microarray, Miltenyi Biotec GmbH, Bergish Galdbach, Germany) as described below. Briefly, 5x106 cells each (primary corneal culture cells as well as immortalized corneal fibroblasts) were lysed in the Trizol(R) reagent (Invitrogen, , CA) and shipped to Miltenyi Biotec GmbH in dry ice. Total RNA was extracted, reverse transcribed, amplified, and fluorescence coupled with Cy3 (primary culture cells) or Cy5 (immortalized corneal fibroblasts) and then hybridized on PIQORTM microarrays. The capture of images and signal quantification were performed by ScanArrayLite (Packard Bioscience, Billerica, MA) and ImaGene software Version 4.1 (BioDiscovery, Los Angeles, CA). Local background was subtracted to obtain net signal intensity, and the Cy5/Cy3 ratios were calculated. The results were analyzed by analysis of variance (ANOVA) test, and the mean ratios of quadruplicate spots were normalized using locally weighted linear regression by LOWESS (locally weighted scatter plot smoothing) normalization method. Only genes displaying net signal intensity twofold higher than the mean background were considered significant and used for further analysis. The products of microarray consisted of genes related to cytokines, interleukins, and growth factors.
###end p 26
###begin title 27
Transfection protocols
###end title 27
###begin p 28
###xml 305 306 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Primary fibroblast cultures were prepared as described above and used when they attained 80% confluence. DMEM:F12 complete medium was removed from each six-well plate containing adherent cells and washed once with PBS. Cells were detached by Accutase(R) (PAA) and resuspended to give a concentration of 105 cells per 100 microl.
###end p 28
###begin p 29
In the transfection assay, the siRNA-couple (Qiagen, Hilden, Germany) for each mRNA was tested along with a control sample using scrambled siRNA to determine changes in cell phenotype, if any. A second control was also done using only the medium without siRNA.
###end p 29
###begin p 30
To ascertain the best suited protocol for transfection of our cells, we have tried three different methods.
###end p 30
###begin title 31
Amaxa(R) transfection protocol
###end title 31
###begin p 32
###xml 661 662 622 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
This is essentially an electroporation protocol consisting of the following: One million cells with 100 microl of Nucleofactortrade mark solution (Amaxa; Lonza, Cologne, Germany) and 2 microg siRNA (for each sample) was mixed in Eppendorf tubes and transferred to Amaxa certified cuvettes at 37 degreesC. The manipulations were quick and lasted less then 15 min to avoid cell mortality and thus adversely affect efficiency of gene transfer. At the end of electroporation, 500 microl of the pre-warmed DMEM:F12 containing serum at 37 degreesC was added to each cuvette. The cells were seeded and incubated for 24 h in a humid atmosphere at 37 degreesC with 5% CO2.
###end p 32
###begin title 33
Hiperfect(R) Qiagen protocol
###end title 33
###begin p 34
###xml 323 324 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 545 546 530 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The siRNA-couple was diluted (37.5 ng/100 mul) in serum free-medium. Three microliters of HiPerfect transfection reagent (Qiagen) was added to the diluted siRNA and mixed by vortexing. The samples were incubated for 10 min at room temperature to allow formation of transfection complexes. These complexes were added onto 105 cells per 100 microl and incubated for 6 h at room temperature after which 300 microl of the medium containing 10% FCS was added in each well and incubated further for 24 h in a humid atmosphere at 37 degreesC with 5% CO2.
###end p 34
###begin title 35
Nanofectin(R) transfection protocol
###end title 35
###begin p 36
###xml 573 574 567 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 824 825 808 809 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The stock solutions of siRNA and Nanofectin siRNA were used at room temperature. Half a microgram of siRNA (i.e. 15 pmol) in 30 microl of serum free-medium was added to each well. Two and a half microliters of Nanofectin (PAA) was added to siRNA in 40 mul of serum free-medium in a second series of wells. The two series of wells were incubated separately for 20 min at room temperature after which the solutions from the first and second series were pooled together giving a final volume of 70 mul for the siRNA nanocomplex mixture. This solution was added drop-wise to 105 cells in 500 microl of medium with or without FCS. The incubation continued at room temperature for 6 h. Cells were pooled and centrifuged. The washed pellet was resuspended for another 24 h incubation in a humid atmosphere at 37 degreesC with 5% CO2. At the end of the incubation and for each transfection protocol tested, a viability test with Trypan Bleu(R) (Sigma-Aldrich) was performed and the number of living and dead cells was determined.
###end p 36
###begin title 37
PCR procedure
###end title 37
###begin p 38
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Total RNA was extracted from primary corneal fibroblasts using Nucleospin RNA-II kit (Macherey-Nagel, Hoerdt, France). Cells (5x106) were lysed at 0 degreesC, and RNA and DNA were selected on the silicate membrane. DNA was degraded directly on the silicate membrane using DNase I for 15 min at room temperature. Following several washes, total RNA was eluted with RNase free water and the integrity of RNA verified on a 2% agarose gel (Sigma-Adrich) in 0.45% ethidium bromide and quantified by spectrometry at the wavelength of 260-280 nm. One microgram of total RNA was used for reverse transcription to create cDNA according to the standard protocol. We used the following synthetic primers (Eurobio, Paris, France): VEGFR-1 sense 5'-CAC CAA GAG CGA CGT GTG-3', antisense 5'-TTT TGG GTC TCT GTG CCA G-3' (196 bp) and beta2microglobulin sense 5'-CCA GCA GAG AAT GGA AAG TC-3', antisense 5'-GAT GCT GCT TAC ATG TCT CG-3'.
###end p 38
###begin p 39
###xml 217 218 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 445 450 <span type="species:ncbi:9606">human</span>
The reaction mixture consisted of 15 ng of cDNA and 2.5 units Taq polymerase (GibCo BRL, Paisley, UK), and the amplification was performed according to the protocol recommended by GibCo BRL. The melting temperature (Tm) for VEGFR-1 and for beta2microglobulin was 60 degreesC. Polymerase chain reaction (PCR) products were analyzed on 2% agarose gel electrophoresis in 0.45% ethidium bromide. The PCR cycle number was normalized to the amount of human beta2-microglobulin cDNA product.
###end p 39
###begin title 40
Statistical analysis
###end title 40
###begin p 41
The Fischer test: statistical analysis was performed using the modified FISHER test. The data was expressed as standard error of the mean (SEM). A p value less than 0.05 was considered statistically significant.
###end p 41
###begin title 42
Results
###end title 42
###begin title 43
Network formation by corneal fibroblasts on Matrigeltrade mark
###end title 43
###begin p 44
###xml 57 65 57 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 427 438 418 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A,B</xref>
###xml 456 467 447 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C,D</xref>
###xml 655 657 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
Network formation of corneal fibroblasts is presented in Figure 1. Primary culture cells from 62 donors were seeded on Matrigeltrade mark. Corneal cells from 51 donors (82%) organized into tubules while 11 donors (18%) remained dispersed (unorganized). These results suggest that the corneal fibroblasts from donors belong to two distinct categories and can be classified into type 1 and type 2 according to whether they form (Figure 1A,B) or do not form (Figure 1C,D) a network on Matrigeltrade mark. Normally, after 2 h, cell network formation starts, and cell-cell interaction lead to the formation of a cell network as described in "Reticulogenesis" [25].
###end p 44
###begin p 45
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 76 77 76 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 239 240 239 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 334 335 334 335 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Network formation by corneal fibroblasts on Matrigel. Type-1(A) and type-2 (C) corneal fibroblasts were seeded on matrigel and photographed before incubation, representing time 0. The same plates were photographed after 2 h of incubation. B (type-1 corneal fibroblast) shows cell elongation and beginning of network formation whereas D (type-2 fibroblast) shows no network formation, and resembles the unincubated controls at time 0.
###end p 45
###begin title 46
Gene array analysis
###end title 46
###begin p 47
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF-A</italic>
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF-C</italic>
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-1</italic>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRP1</italic>
###xml 159 166 159 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-2</italic>
###xml 168 175 168 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-3</italic>
###xml 181 187 181 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF-D</italic>
Table 1 indicates that corneal fibroblasts in primary culture (n=4) or the immortalized cell line (n=1) express VEGF-A, VEGF-C, VEGFR-1, and NRP1 mRNA but not VEGFR-2, VEGFR-3, and VEGF-D mRNA. These results were also confirmed by reverse transcription polymerase chain reaction (RT-PCR) analysis using specific primers.
###end p 47
###begin title 48
Gene array analysis.
###end title 48
###begin p 49
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 6 11 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR</italic>
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRP</italic>
###xml 40 45 <span type="species:ncbi:9606">human</span>
VEGF, VEGFRs and NRP mRNA expression by human corneal fibroblast cells. Column 1indicates the names of different genes that were tested by gene array. Column 2 indicates their corresponding UniGene code. Column 3 shows whether the gene was positive or negative for mRNA expression.
###end p 49
###begin title 50
Demonstration of VEGFR-1 protein in corneal fibroblasts
###end title 50
###begin p 51
###xml 136 145 136 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 233 242 233 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2C</xref>
###xml 272 283 272 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B,D</xref>
The presence of VEGFR-1 was determined by immunofluorescence. A significant level of VEGFR-1 was expressed by type 1 donor fibroblasts (Figure 2A) whereas the VEGFR-1 immunoreactivity was low in corneal fibroblasts of type 2 donors (Figure 2C). Anti-VEGFR-2 was negative (Figure 2B,D).
###end p 51
###begin p 52
###xml 166 167 166 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 314 315 314 315 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 318 319 318 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 334 335 334 335 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Demonstration of VEGFR1 protein in corneal fibroblasts by immunofluorescence. The presence of VEGFR1 was investigated using antibodies specific to VEGFR1 and VEGFR2. A: Significant levels of VEGFR1-specific fluorescence in type 1 donor fibroblasts. VEGFR1 immunoreactivity was undetectable in type 2 donors cells (C). B (type -1) and D (type-2) represent cells treated with anti-VEGFR2 antibodies, providing negative controls.
###end p 52
###begin title 53
Induction of corneal fibroblast network by VEGF
###end title 53
###begin p 54
###xml 139 147 139 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 284 295 284 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A,B</xref>
###xml 384 395 384 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3C,D</xref>
###xml 481 490 472 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3E</xref>
To ascertain the role of VEGF receptors in the corneal fibroblast network formation, two groups of cells, type 1 and type 2, were studied. Figure 3 shows that the addition of exogenous VEGF (100 ng/ml) significantly increased the number of cell interconnections in only type 1 cells (Figure 3A,B). These results also indicate that type 2 fibroblasts do not respond to exogenous VEGF (Figure 3C,D). The number of tubules formed on Matrigeltrade mark at 3 h and 18 h is presented in Figure 3E.
###end p 54
###begin p 55
###xml 56 58 56 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">. </bold>
###xml 98 99 98 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</bold>
###xml 195 196 195 196 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 214 215 214 215 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 281 282 281 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 300 301 300 301 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 363 363 363 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 371 371 371 371 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
Figure-3 Induction of corneal fibroblast network by VEGF. The addition of exogenous VEGF (100 ng/ml), significantly increased the number of cell inter-connections in only type 1 cells after 3 h (A) and after 18 h (B). Type 2 fibroblasts do not respond to exogenous VEGF after 3 h (C) and after 18 h (D). The number of tubules formed on Matrigel counted after at 3h and 18h and are presented in E.
###end p 55
###begin title 56
Induction of corneal fibroblast migration by VEGF-A and VEGF-C
###end title 56
###begin p 57
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 182 193 182 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4A-E</xref>
###xml 238 249 238 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4F-I</xref>
###xml 295 306 295 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4B,F</xref>
###xml 391 402 391 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4C,G</xref>
###xml 416 427 416 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4D,H</xref>
###xml 578 589 578 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4E,I</xref>
###xml 797 805 797 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 856 865 856 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4J</xref>
As shown in Figure 4, cell motility and adhesion were counted using the "wound healing assay" at 9 h, 18 h, 24 h, 48 h, and 72 h (arrows indicate the site of freshly created scars). Figure 4A-E are micrographs after 24 h incubation while Figure 4F-I are pictures taken after 72 h of incubation. Figure 4B,F are untreated samples which serve as controls. Exposure of culture cells to VEGF-A (Figure 4C,G) and VEGF-C (Figure 4D,H) significantly increased cell migration . However, cell migration was adversely affected when an anti-VEGF, Avastin, was added to the culture medium (Figure 4E,I). Avastin-mediated inhibition clearly suggests that the VEGFs play an important role in corneal fibroblast cell motility. The quantitative analysis of the cell number in different conditions is presented in Figure 4. Quantitative analysis as presented in the graph (Figure 4J) clearly confirms the microscopic observations. The effect of Avastin was noticeable already at 24 h, but at 72 h, cell migration suffered markedly in its presence when compared to controls. In the presence of VEGF-A and VEGF-B, the cell number at 72 h increased 1.5 times as compared to the control cultures, but it decreased 0.5 times instead with Avastin.
###end p 57
###begin p 58
###xml 113 114 113 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 200 200 200 200 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 214 215 214 215 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 274 275 274 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 277 278 277 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 280 282 280 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D,</bold>
###xml 287 288 287 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 318 318 318 318 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 337 338 337 338 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 340 341 340 341 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 343 345 343 345 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H,</bold>
###xml 350 351 350 351 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 405 406 405 406 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 411 412 411 412 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 460 461 460 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 466 467 466 467 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 500 501 500 501 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 506 507 506 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 534 535 534 535 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 540 541 540 541 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 666 666 666 666 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 671 671 671 671 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 676 676 676 676 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 681 681 681 681 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 682 683 682 683 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 690 690 690 690 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 716 717 716 717 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</bold>
Corneal fibroblast migration induced by VEGF-A and VEGF-C as demonstrated by a wound healing assay: Upper panel: A shows a photomicrograph of freshly created scar which is indicated as a space betweenthe two arrows, which serves as a reference for observing cell migration. B, C, D, and E are photomicrographs after 24h incubation while F, G, H, and I are photomicrographs taken after 72 h of incubation. B and F are untreated samples which serve as controls. C and G were treated with VEGF-A, while D and H were treated with VEGF-C. E and I were plates exposed to Avastin. The number of cells migrating into the scar regions were counted in all samples at time 0, 9h, 18h, 24h, 48h, and 72h of incubation and graph J was plotted.
###end p 58
###begin title 59
Behavioral properties of cells transfected with VEGFR siRNA
###end title 59
###begin p 60
###xml 40 48 40 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 99 104 <span type="species:ncbi:9606">human</span>
Immunofluorescence studies presented in Figure 2 indicate that VEGFR-1 proteins are present in the human corneal fibroblast type 1 whereas it is undetectable in type 2. However, both types are negative for the presence of VEFGR-2.
###end p 60
###begin p 61
###xml 131 138 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-1</italic>
###xml 145 153 145 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
###xml 193 201 193 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
###xml 243 250 243 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-1</italic>
###xml 329 336 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-2</italic>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-3</italic>
We have investigated the presence of VEGFR-1 mRNAs in fibroblasts type 1 and type 2 by RT-PCR analysis. Type 1 fibroblasts express VEGFR-1 mRNA (Figure 5, slots B and E) whereas type 2 do not (Figure 5, slots A, C, and D). We also transfected VEGFR-1 specific siRNA into type-1 fibroblasts, using as controls experience negative VEGFR-2 and VEGFR-3 siRNAs or a scrambled siRNA provided by Qiagen.
###end p 61
###begin p 62
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR1</italic>
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR1</italic>
VEGFR1 mRNAs detection in fibroblasts of type 1 and type 2 by RT-PCR. Slots B and E show that type 1 fibroblasts express VEGFR1 mRNA whereas type 2 cells do not (slots A, C, and D). beta2-microglobulin mRNA served as an internal control.
###end p 62
###begin p 63
###xml 473 481 465 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f6">Figure 6</xref>
We compared three methods of cell transfection, namely using: i) Amaxa electroporation, ii) Hiperfect(R) reagent, and iii) Nanofectin(R). Cell viability by trypan blue exclusion was performed at time 0 h and found to be above 95%. We observed that viability was remarkably different for the 3 different methods tested 24 h after transfection (15% of cell viability with Amaxa electroporation, 85% with HiPerfect(R), and 81% with Nanofectin(R)).The results are presented in Figure 6. We have used the Hiperfect(R) method for further experiments because it gave us the best results.
###end p 63
###begin p 64
Cell viability for each of the three methods: electroporation, Hiperfect, and Nanofectin. Determination of cell viability at 0 h and after 24 h for siRNA transfection experiments using electroporation, Hiperfect, and Nanofectin. The result was plotted as a histogram.
###end p 64
###begin p 65
###xml 227 236 209 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f7">Figure 7A</xref>
###xml 257 264 239 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-2</italic>
###xml 269 276 251 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-3</italic>
###xml 456 463 438 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-1</italic>
###xml 471 480 453 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f7">Figure 7B</xref>
###xml 549 556 531 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-2</italic>
###xml 564 573 546 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f7">Figure 7C</xref>
###xml 579 586 561 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-3</italic>
###xml 594 603 576 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f7">Figure 7D</xref>
The plasticity of transfected type 1 fibroblasts was analyzed on Matrigeltrade mark in parallel with control cells. Untreated corneal cells (control) readily organized into networks when grown on Matrigeltrade mark substratum (Figure 7A). Transfection with VEGFR-2 and VEGFR-3 siRNAs or scrambled siRNA (results not shown), which were used as controls as indicated above, gave results comparable to the untreated control. In contrast, cell transfection by VEGFR-1 siRNA (Figure 7B) dramatically decreased cell motility and network formation whereas VEGFR-2 siRNA (Figure 7C) and VEGFR-3 siRNA (Figure 7D) did not significantly affect the network formation.
###end p 65
###begin p 66
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR1</italic>
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR2</italic>
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR3</italic>
###xml 141 142 141 142 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 181 182 181 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 201 207 201 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR1</italic>
###xml 215 216 215 216 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 235 241 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR2</italic>
###xml 253 254 253 254 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 273 279 273 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR3</italic>
###xml 372 373 372 373 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
The plasticity of type 1 fibroblasts transfected with VEGFR1,VEGFR2, and VEGFR3 siRNAs as demonstrated on Matrigel after 18 h of incubation. A: Non transfected corneal fibroblasts; B: transfected with VEGFR1 siRNA; C: transfected with VEGFR2 siRNA; and D: transfected with VEGFR3 siRNA. The number of tubules per field was counted and the mean was plotted as a histogram (E).
###end p 66
###begin p 67
###xml 115 122 115 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-1</italic>
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-2</italic>
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-3</italic>
###xml 187 196 187 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f7">Figure 7E</xref>
###xml 231 238 231 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-1</italic>
###xml 279 286 279 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-2</italic>
###xml 291 298 291 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR-3</italic>
In addition, the number of tubules formed by corneal fibroblast cells transfected with the three different siRNAs (VEGFR-1, VEGFR-2, and VEGFR-3) after 18 h of incubation is presented in Figure 7E. These results confirm again that VEGFR-1 inhibition (and to a much lesser extent VEGFR-2 and VEGFR-3 inhibition) adversely affects tubule forming properties of corneal fibroblast type 1.
###end p 67
###begin p 68
Our results show that the down-regulation of VEGFR-1 synthesis also adversely affects cell motility and network formation. Our data, therefore, suggests that VEGFR-1 is an important actor in the functional organization of corneal stromal fibroblasts.
###end p 68
###begin title 69
Age dependent decrease of VEGFR-1 expression
###end title 69
###begin p 70
###xml 154 162 145 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f8">Figure 8</xref>
Statistical analysis showed that the capacity of corneal fibroblasts to form networks on Matrigeltrade mark is directly related to the age of the donors (Figure 8). Type 1 fibroblast cells predominated the corneal stroma in young donors whereas with increasing age, type 2 fibroblast cells begin to take over. In fact, the 70-90-year-old age group was composed of donors for type 2 fibroblast cells. Our results indicate that the expression of VEGFR-1 decreases with age.
###end p 70
###begin p 71
Distribution of Type 1 and Type 2 fibroblasts as a function of age of donors. Compilation of information yielded from experiments on cell reticulation on Matrigel and the presence or absence of VEGFR1 allowed segregation of donors in the two categories, type 1 and type 2. It was noticed from donor data that type 1 was present in all age groups while type 2 was absent in young individuals (below 60 years). Type 2 was the predominant cell population in aged individuals.
###end p 71
###begin title 72
Discussion
###end title 72
###begin p 73
###xml 744 745 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 1135 1137 1135 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 644 649 <span type="species:ncbi:9606">human</span>
###xml 1035 1040 <span type="species:ncbi:9606">human</span>
Cell reticulation of stromal fibroblasts is a fundamental requisite for lamellar organization in cornea formation. Events that hinder this physiologic process can have heavy consequences. One sees one's surroundings through the corneal structure without even being aware that one is looking through a well organized and structured organ. Its architecture and organization are primordial to its physiologic functions. Large amounts of data have been generated to understand corneal function in diseases and aging. However, much still remains to be understood. For the last few years, we have been focusing our research interest in understanding human corneal functions and notably ECM-associated corneal disorders. In a recently published work [1], we have provided evidence regarding the role of the fibulin family proteins in the organization of supramolecular ECM structures of the cornea. Another major finding that we reported concerns the production of protease type plasminogen activator (t-PA) and their inhibitors (PAI) in the human cornea and the alteration of these secretions (t-PA and PAI) in Schnyder's corneal dystrophy [26,27].
###end p 73
###begin p 74
In the present work, we have attempted to further our current knowledge on the implication of growth factors in stromal networking and organization of the cornea. Our results indicate that some of the corneal fibroblasts can form cell-cell reticulation in vitro, which may be an indication of what is happening in vivo. We can distinguish two cell types (type 1 and type 2). Type 1 cells are the most abundant in individuals up to nearly sixty years of age, whereas type 2 cells make their appearance with increasing age when physiological body functions are affected and vision begins to diminish.
###end p 74
###begin p 75
Cell type 1 properties and functions are intimately related to the expression of growth factor receptor, VEGFR-1. Exposure to antagonist (Avastin) and siRNA abolishes the capacity of these fibroblasts to migrate, establish interdendritic contacts, and organize into a functional reticulum during stromal lamellae formation. The proliferative and migratory effect as well as tubule and junction formation can be enhanced considerably by exogenous addition of VEGFR-1 to in vitro culture cells in our Matrigeltrade mark system. VEGFR-1 therefore has a preeminent role in fibroblast cell migration, interdendritic contact formation, and the functional organization of the reticulum in stromal lamellae. These constitute a cascade of interrelated events leading to the formation of a healthy and functional cornea.
###end p 75
###begin p 76
VEGFR-1 is a high affinity receptor for VEGF-A, VEGF-B, and PlGF. On the other hand, VEGFR-2 is expressed in neither type 1 or 2 cells and therefore is perhaps of no apparent consequence in the structural and functional organization of the cornea.
###end p 76
###begin p 77
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 814 816 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 817 819 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
VEGFR-1 is also expressed in vascular endothelial cells and non-endothelial cells including macrophages and monocytes [28], mesenchymal cells [29], and hematopoietic stem cells [30]. VEGFR-1 signaling is involved in the migration of monocytes/macrophages [31], and it has also been shown that VEGFR-1 plays a role in PlGF-mediated recruitment of hematopoietic stem cells (HSCs) from a quiescent state to a proliferative one in the bone marrow, favoring differentiation, mobilization, and reconstitution of hematopoiesis [32]. The addition of exogenous VEGF to cells seeded on Matrigeltrade mark clearly affected cell motility and contact formation besides increasing cell proliferation. Our observation is in conformity and goes along with the results obtained with the hematopoietic cell system by other authors [25,28].
###end p 77
###begin p 78
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 97 102 <span type="species:ncbi:9606">human</span>
VEGFR-1 blocking antibodies have been shown to prevent migration but not proliferation of HUVEC (human vascular endothelial cells) in response to VEGF-A, thereby indicating the involvement of VEGFR-1 in endothelial cell migration [33]. It has also been suggested that VEGFR-1-mediated signaling preferentially modulate the reorganization of actin via p38 MAPK (Mitogen-activated protein kinases) whereas VEGFR-2 contributes to the reorganization of the cytoskeleton by phosphorylating FAK (focal adhesion kinase) and paxillin (a focal adhesion-associated adaptor protein) [34]. Our results from the gene array show that these molecules are constitutively expressed and may play an autocrine or paracrine role in maintaining hemostasis of corneal fibroblasts. Avastin, a humanized monoclonal VEGF antibody, blocks cell migration, which indicates, though indirectly, the autocrine function of constitutively expressed VEGFs.
###end p 78
###begin p 79
The results of the "wound healing" study confirm the autocrine role of VEGFR-1 in cell type 1 in migration and tubule formation. The decrease in VEGFR-1 expression is related to the diminution of the autocrine function and probably a progressive loss of cell multiplication and cell renewal, which culminates in the appearances of type 2 cells and the gradual development of poor vision.
###end p 79
###begin p 80
In conclusion, the corneal fibroblast reticulations as seen in vitro seem to be related to the level of VEGFR-1 expression, and this expression decreases with age. This may also reflect in vivo. Our observation is significant since in pathological conditions or in age-related vision, diminution manipulations of VEGFR-1 expression may provide a novel treatment approach. Restoring VEGFR-1 function/expression levels may hold promises in treating stromal corneal pathologies in the young as well as aging individuals. Development of an artificial cornea for the vision deprived is a hope that needs to be sustained through research initiatives. The present work is a preliminary contribution toward achieving this goal.
###end p 80
###begin title 81
Acknowledgments
###end title 81
###begin p 82
###xml 93 109 93 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fondation Dalloz</italic>
###xml 118 131 118 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R&#233;tina France</italic>
###xml 64 69 <span type="species:ncbi:9606">human</span>
The authors thank the "banque francaise des yeux" for supplying human corneas. We thank also Fondation Dalloz and the Retina France for supporting this study.
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
###xml 71 76 <span type="species:ncbi:9606">human</span>
Expression of extracellular matrix proteins fibulin-1 and fibulin-2 by human corneal fibroblasts.
###end article-title 84
###begin article-title 85
Keratocyte and fibroblast phenotypes in the repairing cornea.
###end article-title 85
###begin article-title 86
###xml 53 58 <span type="species:ncbi:9606">human</span>
Novel aspects of the ultrastructural organization of human corneal keratocytes.
###end article-title 86
###begin article-title 87
###xml 103 109 <span type="species:ncbi:9986">rabbit</span>
Interactions of extracellular collagen and corneal fibroblasts: morphologic and biochemical changes of rabbit corneal cells cultured in a collagen matrix.
###end article-title 87
###begin article-title 88
Antisera directed against connexin43 peptides react with a 43-kD protein localized to gap junctions in myocardium and other tissues.
###end article-title 88
###begin article-title 89
Corneal keratocytes: in situ and in vitro organization of cytoskeletal contractile proteins.
###end article-title 89
###begin article-title 90
Freeze-fracture studies of the developing cell surface. I. The lasmalemma of the corneal fibroblast.
###end article-title 90
###begin article-title 91
Initial characterization of whole-cell currents from freshly dissociated corneal keratocytes.
###end article-title 91
###begin article-title 92
Differential diagnosis between granular corneal dystrophy Groenouw type I and paraproteinemic crystalline keratopathy.
###end article-title 92
###begin article-title 93
Reis-Bucklers' corneal dystrophy.
###end article-title 93
###begin article-title 94
Morphological characteristics and intercellular connections of corneal keratocytes.
###end article-title 94
###begin article-title 95
Corneal avascularity is due to soluble VEGF receptor-1.
###end article-title 95
###begin article-title 96
Molecular mechanisms of VEGF-A action during tissue repair.
###end article-title 96
###begin article-title 97
VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
###end article-title 97
###begin article-title 98
###xml 143 148 <span type="species:ncbi:9606">human</span>
Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells.
###end article-title 98
###begin article-title 99
Lymphangiogenic growth factors, receptors and therapies.
###end article-title 99
###begin article-title 100
Pathways targeting tumor lymphangiogenesis.
###end article-title 100
###begin article-title 101
Structure and function of vascular endothelial growth factor receptor-1 and -2.
###end article-title 101
###begin article-title 102
###xml 96 101 <span type="species:ncbi:9606">human</span>
Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.
###end article-title 102
###begin article-title 103
###xml 85 90 <span type="species:ncbi:9606">human</span>
Expression of vascular endothelial growth factor and its receptors (flt-1) in morbid human corneas and investigation of its clinic importance.
###end article-title 103
###begin article-title 104
###xml 50 55 <span type="species:ncbi:9606">human</span>
IFN-gamma acts as anti-angiogenic cytokine in the human cornea by regulating the expression of VEGF-A and sVEGF-R1.
###end article-title 104
###begin article-title 105
Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier.
###end article-title 105
###begin article-title 106
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.
###end article-title 106
###begin article-title 107
###xml 102 106 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.
###end article-title 107
###begin article-title 108
Vasculogenic mimicry of acute leukemic bone marrow stromal cells.
###end article-title 108
###begin article-title 109
Secretion of plasminogen activators and their inhibitors in corneal fibroblasts. Modification of this secretion in Schnyder's corneal dystrophy.
###end article-title 109
###begin article-title 110
Production of proteases type plasminogen activator and their inhibitor in cornea.
###end article-title 110
###begin article-title 111
###xml 71 76 <span type="species:ncbi:9606">human</span>
The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes.
###end article-title 111
###begin article-title 112
Mesenchymal stem cells can be differentiated into endothelial cells in vitro.
###end article-title 112
###begin article-title 113
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.
###end article-title 113
###begin article-title 114
Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages.
###end article-title 114
###begin article-title 115
Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.
###end article-title 115
###begin article-title 116
###xml 90 95 <span type="species:ncbi:9606">human</span>
Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
###end article-title 116
###begin article-title 117
###xml 88 93 <span type="species:ncbi:9606">human</span>
Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway.
###end article-title 117

